BioMarin Pharma (BMRN) Tops Q4 EPS by 17c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results
February 26, 2020 4:05 PM ESTSAN RAFAEL, Calif., Feb. 26, 2020 /PRNewswire/ --
Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)
Three Months Ended December 31,
Twelve Months Ended December... More
